How can pharmaceutical teams scale systematic literature reviews across therapeutic areas while maintaining accuracy and keeping evidence current?
MadeAi partnered with a clinical team at a top 15 pharmaceutical manufacturer to deploy MadeAi-LR across ten therapeutic areas, supporting both internal teams and CRO partners. The platform achieved 90% accuracy and 40% time savings, while helping lower operational costs and scale evidence operations.
The solution integrated with Ovid and iMedical Search and combined AI-assisted title and abstract screening, evidence synthesis, Clinical Overview Report drafting, and Living Literature Review monitoring to keep completed reviews current. Expert validation, governance, training, and ongoing support supported adoption across internal and external teams.
See how MadeAi helped scale systematic literature review into an AI-enabled enterprise evidence operation.
